BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 28275807)

  • 1. [Efficacy of semiconductor laser therapy combined with botulinum toxin A type injection in treatment of temporomandibular disorders].
    Jiang MY; You QL
    Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):758-761. PubMed ID: 28275807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
    Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
    J Headache Pain; 2016; 17():29. PubMed ID: 27011213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A(BTX - A)for treatment of temporomandibular disorder.
    Zhang LD; Liu Q; Zou DR; Yu LF
    Br J Oral Maxillofac Surg; 2016 Sep; 54(7):736-40. PubMed ID: 27138229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Botulinum Toxin Type A on Pain among Trigeminal Neuralgia, Myofascial Temporomandibular Disorders, and Oromandibular Dystonia.
    Yoshida K
    Toxins (Basel); 2021 Aug; 13(9):. PubMed ID: 34564609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular botulinum toxin injection additional to arthrocentesis in the management of temporomandibular joint pain.
    Ivask O; Leibur E; Akermann S; Tamme T; Voog-Oras Ü
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Oct; 122(4):e99-e106. PubMed ID: 27496577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations.
    Freund BJ; Schwartz M
    Br J Oral Maxillofac Surg; 2003 Oct; 41(5):351-2. PubMed ID: 14581034
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of recurrent dislocation of the temporomandibular joint with type A botulinum toxin.
    Daelen B; Thorwirth V; Koch A
    Int J Oral Maxillofac Surg; 1997 Dec; 26(6):458-60. PubMed ID: 9418151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of botulinum toxin type A for the treatment of habitual dislocation of the temporomandibular joint.
    Fu KY; Chen HM; Sun ZP; Zhang ZK; Ma XC
    Br J Oral Maxillofac Surg; 2010 Jun; 48(4):281-4. PubMed ID: 19665263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for the treatment of temporomandibular joint disk disfigurement: clinical experience.
    Karacalar A; Yilmaz N; Bilgici A; Baş B; Akan H
    J Craniofac Surg; 2005 May; 16(3):476-81. PubMed ID: 15915120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinum toxin A: analgesic treatment for temporomandibular joint disorders].
    Denglehem C; Maes JM; Raoul G; Ferri J
    Rev Stomatol Chir Maxillofac; 2012 Feb; 113(1):27-31. PubMed ID: 22240328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing change in functional outcomes and quality of life in myogenic temporomandibular disorders undergoing botulinum toxin injection: A before and after comparison.
    Hosgor H; Coskunses FM; Altindis S
    J Stomatol Oral Maxillofac Surg; 2023 Sep; 124(4):101434. PubMed ID: 36914004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive monitoring of changes in the structure and function of masseter muscles after the injection of botulinum toxin type A].
    Guo Z; Diao X; Xia W; Liu T; Chen Y; Zheng J; Zhou Z; Yang P; Zhu J
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Nov; 32(6):437-40. PubMed ID: 30067323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of temporomandibular disorders with botulinum toxin.
    Schwartz M; Freund B
    Clin J Pain; 2002; 18(6 Suppl):S198-203. PubMed ID: 12569969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IncobotulinumtoxinA Injection for Temporomandibular Joint Disorder.
    Patel AA; Lerner MZ; Blitzer A
    Ann Otol Rhinol Laryngol; 2017 Apr; 126(4):328-333. PubMed ID: 28290229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Aspects of the Use of Botulinum Toxin Type A in the Treatment of Dysfunction of the Masticatory System.
    Bogucki ZA; Kownacka M
    Adv Clin Exp Med; 2016; 25(3):569-73. PubMed ID: 27629747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does laser inactivate botulinum toxin?
    Semchyshyn NL; Kilmer SL
    Dermatol Surg; 2005 Apr; 31(4):399-404. PubMed ID: 15871314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Adjunctive Botulinum Toxin A Reduce Pain Scores When Combined With Temporomandibular Joint Arthroscopy for the Treatment of Concomitant Temporomandibular Joint Arthralgia and Myofascial Pain?
    Thomas NJ; Aronovich S
    J Oral Maxillofac Surg; 2017 Dec; 75(12):2521-2528. PubMed ID: 28500876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of type a botulinum toxin injections and infrared polarized light on treating chronic migraine.
    Song JH; Zhang GB; Ding XD; Huang L; Hong Y; Chen HX
    Eur Rev Med Pharmacol Sci; 2015; 19(11):1976-82. PubMed ID: 26125257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of articular disc loading in the temporomandibular joints after prosthetic and pharmacological treatment in model studies.
    Pihut ME; Margielewicz J; Kijak E; Wiśniewska G
    Adv Clin Exp Med; 2017; 26(3):455-460. PubMed ID: 28791820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.